Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 760 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Tarlatamab Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer MOST POPULAR Implementation of Molecular Tumour Board Portal Developed Under the Umbrella of... May 25, 2022 Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Improves EFS and OS in Cisplatin-Eligible... November 18, 2024 European Parliament Adopts Its Position on the Critical Medicines Act, Strengthening... January 22, 2026 Single Mom Has To Beg For Rides To Doctor For Son... March 14, 2019 Load more HOT NEWS Longer Follow-Up Continues to Support First-Line Pembrolizumab Plus Chemotherapy in Metastatic... Access to Cancer Medicines and Clinical Trials Show Stark Variations Across... 3…2…1…Countdown to Medicare Open Enrollment Simple Hysterectomy May Expand Treatment Options for Early-Stage Cervical Cancer
